To access the carrier product and rate information provided by PRISM, check the box below indicating you have read and agree to the license agreement. A button will then appear to access PRISM.
This site uses cookies to track your agreement option. If the terms of the license agreement change or if you clear the cookies from your browser, this page will appear once again during the PRISM login process.
New Cigna + Oscar (C+O) small group sales and renewals will not be offered in 2025. At C+O’s request, all plans and rates have been removed from the quote engine. However, you can still quote or renew your C+O groups through December 15, 2024 by contacting us at quotes@claremontcompanies.com or 800.696.4543. Please note: the last day of coverage will be December 14, 2025.
For assistance, please contact our Quotes team at quotes@claremontcompanies.com or 800.696.4543.
Login To Prism
The Inflation Reduction Act of 2022 (IRA) was signed into law by President Biden on August 16, 2022. While group health benefits are not directly impacted, health insurance professionals will want to be aware of several healthcare and health insurance provisions in the bill.
Increased premium tax credits for low-income individuals, which were implemented in the 2021 American Rescue Plan Act, were set to expire at the end of 2022. IRA extends the increased premium subsidies through 2025.
Prescription Drug Price Negotiation by Medicare
IRA allows for the first time the Centers for Medicare & Medicaid Services (CMS) to negotiate drug prices under Medicare Parts B & D.
$2,000 Annual Cap on Medicare Part D
IRA places a $2,000 annual cap on out-of-pocket costs for prescription drugs under Medicare Part D, starting in 2025.
Penalties if Drug Companies Increase Prices Faster Than Inflation
IRA places inflation caps in Medicare Part D that limit price increases for drugs year over year. Tax penalties will be levied on drugmakers that increase the prices of their products more than the rate of inflation.
$35 Out-of-Pocket Cost Limit on Insulin
IRA places a $35 out-of-pocket cost limit on insulin for individuals under Medicare.
Questions?
Contact The Answer Team at 800.696.4543 or info@claremontcompanies.com.
Get The Latest News with Text Messaging!
Your success is important to us, and we’re actively working on new solutions to support you throughout the year. To get the latest news via text messaging in the future, simply provide your cell phone number here.